The present invention relates to aqueous pharmaceutical compositions comprising a high concentration (i.e., greater than 50 milligrams per milliliter) of adalimumab (including antibody proteins considered or intended as “biosimilar” or “bio-better” variants of commercially available adalimumab) suitable for long-term storage, and methods of manufacture of the compositions; methods of their administration; and articles containing the same.
本发明涉及包含适合长期储存的高浓度(即每毫升大于 50 毫克)阿达木单抗(包括被认为或打算作为市售阿达木单抗的 "
生物类似物 "或 "
生物更优 "变体的
抗体蛋白)的
水性药物组合物,以及该组合物的制造方法、给药方法和含有该组合物的物品。